4//SEC Filing
Weisman Harlan F 4
Accession 0001213900-19-021426
CIK 0001733413other
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 8:34 PM ET
Size
7.0 KB
Accession
0001213900-19-021426
Insider Transaction Report
Form 4
Weisman Harlan F
Director
Transactions
- Purchase
Common Stock
2019-10-25$5.00/sh+5,000$25,000→ 5,000 total - Award
Stock Options (Right to Buy)
2019-10-29+43,794→ 135,806 totalExercise: $5.00Exp: 2029-10-29→ Common Stock (43,794 underlying)
Footnotes (2)
- [F1]The shares of common stock purchased in the Issuer's initial public offering.
- [F2]25% of the options vest on the first anniversary of the grant and the remainder vest in equal quarterly installments over the next three years.
Documents
Issuer
TFF Pharmaceuticals, Inc.
CIK 0001733413
Entity typeother
Related Parties
1- filerCIK 0001555563
Filing Metadata
- Form type
- 4
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 8:34 PM ET
- Size
- 7.0 KB